Related Experiment Video
Updated: Jul 28, 2026

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
Published on: October 9, 2017
Carfentanil Use in a Patient Undergoing Treatment for Substance Use Disorder
Tom Tuzel1, Stephanie Marina Bollini2, James P Antara2
1Behavioral Enhancement and Substance Abuse Treatment, PLLC, Deer Park, NY.
Abstract:
Carfentanil is a synthetic opioid approximately 10,000 times as powerful as morphine. It is not approved for human use. However, cases of death associated with carfentanil have become more frequent in recent years. In this report, the case of a patient with a positive urine test for norcarfentanil (a metabolite of carfentanil) is described. The analytical method leading to the detection is summarized. This is a rarely reported case of survival of carfentanil use. It is unique in the published literature of an account of a norcarfentanil-positive patient concurrently enrolled in a substance use disorder treatment program. To the authors' knowledge, this is the first documented case of a carfentanil exposure in the state of New York.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Cardiopulmonary Resuscitation IV: Pharmacological Management

